Glakolens
Latest round
- Seed
Last raised
- May 2017
Total raised
- $0.5M
Investors
- 1
About Glakolens
Founded by Arda Yalcinkaya, Gunhan Dundar, and Hamdi Torun, GlakoLens operates out of Istanbul, Turkey. The company focuses on innovative health monitoring solutions through contact lenses designed for users managing diabetes and similar health conditions.GlakoLens primarily focuses on the development of non-invasive biosensors that are embedded in contact lenses. These innovative biosensors are designed to monitor various health metrics, providing users with real-time data that can help manage conditions such as diabetes and other health-related issues. The core functionality of these products includes the ability to detect biochemical markers through the tear fluid, offering a seamless integration of health monitoring into daily life without the need for traditional invasive procedures. The company targets health-conscious consumers and individuals with specific medical needs, ensuring that their products cater to both everyday wearers and those requiring continuous health monitoring.The revenue model for GlakoLens is centered around direct-to-consumer sales and potential partnerships with healthcare providers and retail distributors. The company anticipates transactional structures that may involve consumers purchasing their biosensor contact lenses through online platforms or authorized retailers. Flagship products are expected to be priced competitively within the health tech market, catering to various consumer segments, including individuals managing chronic health conditions and proactive health enthusiasts. Revenue generation will also be supported by collaborations with healthcare institutions that may integrate GlakoLens products into their patient care protocols.GlakoLens is focused on expanding its product line with new biosensing technologies set to launch in the upcoming year. The company is strategically targeting North American and European markets for expansion, with plans to establish a presence by the end of 2024.470 million will be utilized to support product development and market entry strategies, enhancing the company's capabilities in delivering innovative health monitoring solutions.
Who invested in Glakolens
1 investor across 1 round
See all investors in Glakolens
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 24, 2017
Amount
$0.5M
Investors
Questions about Glakolens
Who invested in Glakolens?
Glakolens has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Glakolens raised?
Glakolens has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Glakolens last raise money?
Glakolens's most recent round on record is a Seed, in May 2017.
What does Glakolens do?
Founded by Arda Yalcinkaya, Gunhan Dundar, and Hamdi Torun, GlakoLens operates out of Istanbul, Turkey.
Where is Glakolens headquartered?
Glakolens is headquartered in Istanbul, Turkey.
Which VCs invest in companies like Glakolens?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Glakolens's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Glakolens? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.